| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Activity1
University of Colorado Health Sciences Center, Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine (C.L.M., R.H.E., T.M.), Department of Pediatrics (M.J.P.), and Center for Human Nutrition (C.L.M., R.H.E., M.J.P.), Denver, Colorado 80262
Address all correspondence and requests for reprints to: Catherine Morin, University of Colorado Health Sciences Center, 4200 East 9th Avenue, C225, Denver, Colorado 80262. E-mail: Catherine.Morin{at}uchsc.edu
Adipose tissue-derived tumor necrosis factor-
(AT-TNF) has been
associated with genetic models of insulin resistance and obesity. It is
presently unknown if secreted AT-TNF protein is bioactive or whether it
can be increased by environmentally induced obesity. In this study,
male Wistar rats were fed either a low fat (LF; 12% of energy from
corn oil) or a high fat (HF; 45% of energy from corn oil) diet for 5
weeks. From previous data, it is known that after 3 weeks, HF fed
animals are obese and insulin resistant compared with the LF group.
Hence, animals were killed at 1 week of HF feeding, during the acute
response to the diet, and at 5 weeks, when differences in body fat are
manifest. Weight gain was significantly increased by diet
(P = 0.03) and time (P <
0.0001). AT-TNF bioactivity was measured on secreted protein collected
from medium of minced, incubated epididymal (EPI), mesenteric (MES),
and retroperitoneal (RETRO) fat pads. AT-TNF bioactivity was
significantly increased by diet (P = 0.003) in the
RETRO pad and tended to increase (P = 0.07) in EPI.
AT-TNF activity was unaffected by diet or time in the MES pad. In the
RETRO pad, TNF activity correlated negatively with RETRO fat cell
number (r = -0.46, P = 0.002). Secreted
AT-TNF protein did not correlate with AT-TNF activity but instead
decreased in RETRO with time but not diet. In EPI, secreted AT-TNF
protein decreased with the HF diet. Thus, these data suggest that high
fat diets and obesity can influence AT-TNF bioactivity and secretion
but in an apparent fat pad-specific manner.
This article has been cited by other articles:
![]() |
H. Wu, L. Wei, Y. Bao, J. Lu, P. Huang, Y. Liu, W. Jia, and K. Xiang Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E628 - E634. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Neels, M. Pandey, G. S. Hotamisligil, and F. Samad Autoamplification of Tumor Necrosis Factor-{alpha}: A Potential Mechanism for the Maintenance of Elevated Tumor Necrosis Factor-{alpha} in Male but Not Female Obese Mice Am. J. Pathol., February 1, 2006; 168(2): 435 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wu, P. Brouckaert, and T. Olivecrona Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-{alpha} is involved Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E711 - E717. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, X. Yu, W. Pan, and R. H. Unger Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1334 - E1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fruhbeck, J. Gomez-Ambrosi, F. J. Muruzabal, and M. A. Burrell The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E827 - E847. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Murray, A. D. Sniderman, P. J. Havel, and K. Cianflone Acylation Stimulating Protein (ASP) Deficiency Alters Postprandial and Adipose Tissue Metabolism in Male Mice J. Biol. Chem., December 17, 1999; 274(51): 36219 - 36225. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Murray, A. D. Sniderman, and K. Cianflone Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E474 - E480. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Morin, E. C. Gayles, D. A. Podolin, Y. Wei, M. Xu, and M. J. Pagliassotti Adipose Tissue-Derived Tumor Necrosis Factor Activity Correlates with Fat Cell Size But Not Insulin Action in Aging Rats Endocrinology, December 1, 1998; 139(12): 4998 - 5005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guerre-Millo, P. Gervois, E. Raspe, L. Madsen, P. Poulain, B. Derudas, J.-M. Herbert, D. A. Winegar, T. M. Willson, J.-C. Fruchart, et al. Peroxisome Proliferator-activated Receptor alpha Activators Improve Insulin Sensitivity and Reduce Adiposity J. Biol. Chem., May 26, 2000; 275(22): 16638 - 16642. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |